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The role of Kono-S anastomosis and mesenteric resection in reducing recurrence after 
surgery for Crohn’s disease.   A systematic review.
Alshantti A, Hind D, Hancock L, Brown SR, 
Abstract
Objectives
Recurrence after surgery for Crohn’s disease is common. Anastomotic configuration may 
influence recurrence and the mesentery may be key.  Recently the Kono-S anastomosis and 
radical mesenteric excision have been proposed as methods of reducing recurrence. We 
analysed the literature pertaining to these novel techniques
Methods
We searched MEDLINE, EMBASE and the Cochrane Library for, and selected, studies 
evaluating Kono-S anastomosis and/or radical mesenteric excision in Crohn’s disease.  
We assessed methodological quality and risk of bias using the Cochrane risk of bias tool for 
randomized controlled trials and the Joanna Briggs Institute tool for non randomized trials.  
Narrative synthesis was used to summarise the findings.
Results 
Nine studies (896 patients) were identified.  Apart from one RCT with a low risk of bias the 
overall level of evidence was poor (Grade IV).  The Kono-S anastomosis was associated with 
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Complications, particularly anastomotic leak rate were also lower (1.8% vs 9.3% 
respectively).  Evidence from a single poor quality study suggested that mesenteric excision 
may reduce surgical recurrence rates when compared mesentery preservation.
Discussion
Existing literature suggests the Kono-S anastomosis is safe and may reduce endoscopic and 
surgical recurrence, but level of evidence is mainly poor.  One element of the Kono-S 
technique, preservation of the mesentery, may be detrimental to recurrence.  Further, higher 
quality, studies are required to investigate these techniques. Such studies should consider the 





Recurrence after surgery for Crohn’s disease is common. Anastomotic configuration may 
influence recurrence and the mesentery may be key.  Recently the Kono-S anastomosis and 
radical mesenteric excision have been proposed as methods of reducing recurrence. We 
analysed the literature pertaining to these novel techniques
Data sources
We searched MEDLINE, EMBASE and the Cochrane Library for, and selected, studies 
evaluating Kono-S anastomosis and/or radical mesenteric excision in Crohn’s disease.  
Review methods
We assessed methodological quality and risk of bias using the Cochrane risk of bias tool for 
randomized controlled trials and the Joanna Briggs Institute risk of bias tool for non 
randomized trials.  Narrative synthesis was used to summarise the findings.
Results 
Nine studies (896 patients) were identified.  Apart from one RCT, with a low risk of bias, the 
overall level of evidence was poor (Grade IV).  The Kono-S anastomosis was associated with 
a lower incidence of endoscopic and surgical recurrence (0-3.4% vs 15-24.4% respectively).  
Complications, particularly anastomotic leak rate, were also lower (1.8% vs 9.3% 
respectively).  Evidence from a single poor quality study suggested that mesenteric excision 
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Existing literature suggests the Kono-S anastomosis is safe and may reduce endoscopic and 
surgical recurrence, but level of evidence is mainly poor.  One element of the Kono-S 
technique, preservation of the mesentery, may be detrimental to recurrence.  Further higher 
quality studies are required to investigate these techniques. Such studies should consider the 
impact of the degree of mesenteric resection in addition to anastomosis on disease recurrence. 
Word count 247
Introduction
Crohn’s disease is a well recognised chronic inflammatory condition of the gastrointestinal 
tract.   Notwithstanding the relatively high incidence, particularly in the West, the underlying 
aetiology remains elusive.  Optimal treatment involves a multidisciplinary approach 
including gastroenterologists, surgeons, radiologists and nursing staff (1,2).   Despite 
advances in all aspects of treatment, Crohn’s disease remains incurable and relapse and 
recurrence are common (2,3).   
After surgical resection it is recognised that the majority of recurrences occur at and proximal 
to the anastomosis, implying that the surgery itself may have a role, with faecal stasis a 
possible underlying aetiology.   With this in mind numerous studies have explored the effect 
of anastomotic configuration on recurrence. Whilst there have been several studies and meta-
analyses, results remain conflicting (4-6).  Current consensus supports a wide lumen 
configuration, most easily accomplished with a stapled side-to-side anastomosis (2,3). 
Recently a novel anastomotic configuration has been described (7).  The Kono-S anastomosis 
is a combination of stapled and hand sewn techniques with 3 underlying principles;- 
mesentery preservation, a supporting column to prevent anastomotic distortion, and an anti-
mesenteric anastomosis based on endoscopic observations that recurrence occurs initially on 
the mesenteric border (8) and that anti-mesenteric strictureplasty does not tend to lead to site 
specific recurrence (9).  Several studies suggest this technique results in a dramatic reduction 
in surgical recurrence.  However, a thorough systematic review of the literature is absent. 
One particular aspect of the Kono-S anastomosis is preservation of the mesentery.  A 
rationale based on the premise that this preserves vascular and nervous supply to the 










This article is protected by copyright. All rights reserved
to the disease process (10) and a more radical resection of the mesentery is appropriate. 
Given the potential importance of the mesentery and the fact that mesenteric preservation is 
an integral part of the Kono-S technique, studies comparing the degree of mesenteric 
preservation for Crohn’s disease where a Kono-S anastomosis may be considered are also 
relevant to a systematic review.
Our primary aim was to systematically review the literature on the safety and efficacy of the 
Kono-S anastomosis in reducing both endoscopic and surgical recurrence.  A secondary aim 
was to systematically review the literature with regard to the degree of mesenteric 
preservation and its effect on recurrence. 
Methods 
This systematic review followed Cochrane guidelines (11) and the PRISMA statement (12).  
It was registered prospectively on the PROSPERO database (CRD4201913259). 
 
Studies were included if they involved participants of any age who had undergone surgical 
resection for Crohn’s disease.  Interventions included a Kono-S anastomosis to restore bowel 
continuity after Crohn’s resection as well as studies examining the degree of mesenteric 
preservation where a Kono-S anastomosis would have been appropriate.   Where there were 
comparators, these included a standard anastomosis as defined by the study authors.  For 
studies investigating radical mesenteric excision the comparator was mesenteric preservation. 
Primary outcomes included surgical recurrence and endoscopic recurrence, defined by the 
Rutgeerts score.  Secondary safety outcomes included anastomotic leakage, bowel 
obstruction,  and surgical site infections. 
Search strategy
A definitive search strategy of three main bibliographic databases was created in four stages: 
a scoping search was conducted in MEDLINE via PubMed to find related keywords, 
substitutes, and word variants related to the review theme.   Keywords were further 
complemented and translated into free-text search terms.  Then, a ‘comprehensive pearl 
growing’ (13) method using 16 known and topic-relevant studies (3, 7, 14-27) as ‘pearls’, 









This article is protected by copyright. All rights reserved
the free-text search terms and indexed subject headings. Further, search strategies form these 
systematic reviews were checked for related search terms. 
This identified the following MeSH themes;  ‘Crohn Disease’, ‘Crohn’s disease’, 
‘Anastomosis’, ‘Surgical’, ‘Digestive System Surgical Procedures’, Kono-S anastomosis, 
‘Kono’, ‘Functional end-to-end’, ‘mesenter* adj3 resect*’, ‘mesenter* adj3 remov’, 
‘mesenter* adj3 surg* Themes were consecutively entered in the MeSH  function  
MEDLINE via OvidSP (1946 to March 2020), EMBASE via OvidSP (1974 to March 2020) 
the Web of Science (April 2000 to March 2020) and the Cochrane Central Register of 
Controlled Trials (CENTRAL) (to March 2020).  
In addition the following were carried out
- search in ClinicalTrials.gov 
- grey literature search using Google Scholar for the first 200 related citations screened (28).  
The term ‘Kono S ’ and ‘mesenteric’ in combination with one of the following terms was 
successively searched: ‘anastomosis’, ‘Crohn’s’ ‘resection’, ‘surgery’, ‘removal’, ‘sparing’, 
‘intestine’
-  hand search of the Journal of Crohn’s and Colitis and meeting abstracts from the European 
Crohn’s and Colitis Organization. 
- all reference lists of relevant studies from of eligible articles. 
- investigators of included records were contacted to ask about relevant completed, ongoing 
or planned studies and to provide any provisional results. 
Study selection 
Two reviewers (AA, SB) independently reviewed all identified abstracts. There was no 
restriction on the design of the studies included, setting, country of origin, type, status, 
language or date of publication. All relevant papers were obtained in full, evaluated and 
included only with the agreement of both reviewers. Disparities were resolved by consensus 
with arbitration by a third reviewer (DH). For multiple citations of the same study, the 
citation with the most complete data was included.
Data included
1) Study characteristics (study ID, type, country of origin, study period, inclusion/exclusion 
criteria).
2) Patient demographics (Numbers, age, risk factors, gender)
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4) Results for all pre-specified outcomes.
Risk of bias
Risk of bias was assessed and described in the narrative synthesis.  For randomised controlled 
trials (RCT) the Cochrane (RoB2) assessment tool was used. For case series and cohort 
studies the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Case Series was 
used.  As there was only one RCT, we used the Centre for Evidence-Based Medicine Tool 
(CEBM), rather than GRADE, to understand risk of bias across studies.
Synthesis of results 
Statistical synthesis of results was not possible as insufficient data were available. Instead a 
descriptive synthesis is presented. Predefined outcomes are presented in a summary of 
findings table and explained in the text. 
Study results were described in order according to their evidence level, risk of bias, or 




The process of study selection and literature search are shown in Figure 1.  A total of 830 
studies (excluding any duplicates) were identified for screening with 808 discarded on title 
and abstract alone. Twenty two citations underwent a full-text assessment with a further 11 
records excluded. Of the 11 remaining included studies there were two incomplete RCTs (30, 
32).  All studies are summarised in table 1 but Michelassi (30) and Li (32) have been 
excluded from subsequent text and tables.  A total of 896 patients were included.  
Of the included studies, one was classified as an RCT (29), three were comparative studies 
with an historical control (7,14,23) and five were case series (15, 16, 19, 20, 31).  Three 
studies originated from Japan (7,14,19) one each from Italy (29), USA (31) and Germany 
(15) and 3 were multinational (16,20,23).  Follow-up ranged from 12-126 months (median 48 
months).  Participant characteristics are given in table 2.  For the analysis involving the 
Kono-S anastomosis the studies involving a comparator included either end-to-end (14), side-









comparator was preservation of the mesentery (division of the mesentery flush with the 
intestine).   
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Risk of bias 
Table 3 and 4 shows the methodological quality and risk of bias of included studies.  For the 
one RCT overall risk of bias was low, although there lack of clarity over blinding of outcome 
assessment. The overall methodological quality of the five case series studies was generally 
good as they were judged to have a low risk of bias in most domains.  Two exceptions were 
Krane (31) and Fischera (20) because of insufficient information in published form.  All 
except Kono (16) were deemed high risk for statistical analysis due to lack of detail.  
Additionally, follow up duration was deemed inadequate in order to detect surgical 
recurrence in three studies (15, 20, 31).  The comparative studies with historical control were 
deemed low risk in most domains. However, again two of the three studies (7,14) were 
deemed high risk due to inadequate follow up to detect surgical recurrence.
For risk of bias across non-randomized studies, the highest level of evidence was level IV 
(case-series and poor quality cohort and case-control studies) for both the Kono-S and the 
degree of mesenteric excision analysis.
Synthesis of results
Table 5 summarises the primary outcomes of surgical and endoscopic recurrence. 
Surgical recurrence after Kono-S anastomosis 
In general, surgical recurrence was lower in the Kono-S anastomosis group compared with 
the standard anastomosis. Recurrence ranged from 0-3.4% after a median follow up of 35 
months compared with 15-24.4% after a median of 60 months for the comparator 
anastomosis.   
Endoscopic recurrence after Kono-S anastomosis
Endoscopic recurrence was defined using the Rutgeert’s score.  Patients with a score of i,1, or 
less have low-grade mucosal inflammation and are deemed at low risk of symptom 
recurrence (32).   Endoscopic recurrence was significantly lower in the Kono-S group 
compared to the standard anastomosis group.  Results from the RCT (29) showed a mean 
Rutgeerts score of  i,1.05+/-1.06 at 18 months for the Kono-S group compared with i,2.30 +/-
1.32 in the conventional group. A Rutgeerts score of above i,2, indicating a higher risk of 
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compared with 29/43 (67.4%) in the conventional anastomosis group.   Long term data from 
one comparative historical control study (7) also showed a lower score for the Kono-S group 
but the mean score was above i,2 in this group.   Conversely 2 case series suggest a median 
score of less than i,1 at 1 year (20) and 3 years post Kono-S (31). 
Surgical recurrence after mesenteric excision
In one study (23), radical mesenteric excision resulted in surgical recurrence in 2.9% after 51 
months follow up compared with 30% recurrence at 70 months follow up of an historical 
control group where the mesentery was preserved.  There was no endoscopic assessment in 
this study.
Secondary outcomes 
Table 6 shows the results of the secondary outcomes 
Anastomotic leak 
Three studies on the Kono-S anastomosis have sufficient data to allow a comparison of 
anastomotic leak.  The RCT showed no leak in either group although one patient from the 
conventional group developed a fistula (suspicious for a contained leak) (29).  In the Shimada 
study (14), anastomotic leak was significantly lower in Kono S group (5.1% vs 17.3%).   
There was evidence in favour of the Kono-S anastomosis from the Kono 2011 study (7), (0% 
leak Kono-S vs 4.1% comparator).  Overall the leak rate for the Kono-S anastomosis was 
1.8% (11/606) and 9.3% (20/214) for the control group. 
Infection 
Three Kono-S studies compared superficial site infection rates after Kono-S anastomosis with 
a control group (7,14,29).  In the RCT the incidence was the same in both groups.   In one 
comparative study superficial site infection was nearly doubled in the Kono-S group.  Organ 
specific infection rates were also higher in the Kono-S group in this study (14). In the other 
comparative study (7) and the RCT (29) superficial site infection rates were the same in both 
groups. Deep site infection rates were similar in all studies.  Overall the incidence of 
superficial surgical site infection was 7.1% (36/507) for Kono-S and 8.4% (18/214) for the 
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8.9% (19/214) for the comparator anastomosis.   For organ specific infection the incidence 
was 8.5% (13/153) for Kono-S and 12.1% (17/141) for the comparator anastomosis. 
Bowel obstruction  
Intestinal obstruction (ileus) following Kono-S surgery was reported in six studies. Similar 
rates were seen in both the Kono-S and comparator groups.  The overall incidence for the 
Kono-S group was 4.6% (23/501) and 7.0% (12/171) in the comparator group. 
Discussion 
The results of this systematic review suggest that that Kono-S anastomosis is associated with 
a very low incidence of surgical recurrence compared with mainly historical controls utilising 
‘standard’ anastomotic techniques. The technique also reduces endoscopic recurrence, seen 
most convincingly in one RCT.  It appears safe with the limited evidence suggesting that the 
anastomotic leak rate may be lower than seen with ‘standard’ anastomoses. Other 
complications are also low.   Data on mesenteric preservation is limited to one historical 
control comparative study (23) suggesting more radical mesenteric excision results in lower 
recurrence with no comment on safety.  
Some principles of the Kono-S anastomosis make anatomical and pathological sense and may 
explain this low surgical recurrence.  It is recognised that recurrence occurs initially on the 
mesenteric border of an anastomosis, presumably related to the lack of collateral blood 
supply compared with the anti-mesenteric border.  Mesenteric inflammation is more likely to 
compromise the end arterial blood supply of this bowel region whereas more extensive 
inflammation is required to compromise the ‘dual’ supply of the anti-mesenteric bowel (8).  
An anti-mesenteric anastomosis is therefore likely to delay any mesenteric border recurrence 
becoming symptomatic and requiring surgical intervention.  This is particularly the case if the 
resection margin of the bowel is also away from the anastomosis as in the Kono-S.  There are 
similarities between the Kono-S and a strictureplasty where again evidence suggests site 
specific surgical recurrence is low (9). 
If the anti-mesenteric anastomosis is key to delaying surgical recurrence, it follows that 
endoscopic recurrence on the mesenteric border should be similar for the Kono-S and 
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suggest this is not the case.  Endoscopic recurrence is also substantially reduced (29). Why 
this should be remains unexplained.  It is possible that this result is spurious despite being 
seen in an RCT.  There is an element of subjectivity to the Rutgeert’s endoscopic assessment 
tool and it is not possible to blind the endoscopist.   However, if endoscopic recurrence is 
truly reduced it does have implications for on-going and future comparative trials as the 
primary outcome does not necessarily have to be surgical recurrence; prolonged follow up 
(>5 years), whilst preferable, may not be absolutely necessary.  
There is less anatomical evidence for the supporting column aspect of the Kono-S 
anastomosis.  It does make pathological sense as distortion of the anastomosis due to 
inflammation and fibrosis is frequently seen when carrying out redo surgery. The third 
principle of the Kono-S anastomosis is preservation of the mesentery, theoretically 
preserving the neuro-vascular supply of the resection margins.  However, this contradicts 
another school of thought that it is the mesentery that drives recurrence.  Coffey and Li have 
argued this extensively (10, 34).  We were only able to identify one published study 
supporting the concept of radical mesenteric resection (23) and there are significant 
drawbacks to this study with inherent bias and little data about potential harm (10).  Radical 
mesenteric resection is more challenging in the era of laparoscopic surgery, and could lead to 
more extensive bowel resection in order to avoid vascular compromise of resected edges.   
Despite this limited evidence for radical mesenteric resection other data indirectly supports 
the mesenteric disease concept.  de Groof et al. suggested that the presence of mesorectum 
after proctectomy for Crohn’s disease results in a higher incidence of perineal complications 
essentially due to the presence of the pro-inflammatory mesenteric tissue (35). 
There are potential explanations for why both a Kono-S anastomosis with mesenteric 
preservation and radical mesenteric resection techniques might reduce surgical recurrence.  
Both aim to isolate the anastomosis as much as possible from the diseased mesentery.   If true 
it may be that a combination of more radical mesenteric resection and a Kono-S type 
anastomotic configuration is the optimal technique.  An alternative, less plausible, 
explanation (in our view) is the existence of different phenotypes of disease: a mesentery 
dependent phenotype that requires radical excision and a mesentery independent phenotype 
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The strengths of this review are in the comprehensive and unrestricted systematic search 
strategy that included, with confidence, all relevant literature which was rigorously assessed.  
One other recent review only included 5 of the 9 published studies (excluding the one RCT), 
gave minimal comment on endoscopic recurrence and failed to assess risk of bias (37).  
However, both reviews have significant weaknesses in the low volume and mainly poor 
quality of the literature and many of the studies involve one particular author who advocates 
a specific technique.  Some studies may include the same groups of participants. 
Nevertheless, our data does include one higher quality trial where, although follow up was 
too short for conclusions to be drawn about surgical recurrence, does mirror other studies that 
suggest endoscopic recurrence is reduced substantially with a Kono-S anastomosis.  We have 
identified 2 quality trials that are ongoing and these may allow more robust conclusions to be 
drawn (30, 32).  
Further trials are needed because the results so far compellingly suggest that surgery could be 
more effective.  If recurrence rates are indeed reduced by the magnitude suggested, the 
technique will have profound implications in terms of the need for adjuvant medical therapy 
after surgery. Future trials should preferably include long term follow up for surgical 
recurrence and should probably be in the form of a 2 by 2 design to include the extent of 
mesenteric resection as well as anastomosis type.  In the meantime, a well governed registry 
of cases may give useful data as to efficacy and safety of both the Kono-S anastomosis and 
mesenteric resection.  
Conclusion
Whilst the level of evidence is mainly poor, there is a suggestion of a significant reduction in 
endoscopic and surgical recurrence with the Kono-S and the procedure appears safe.  
Whereas the Kono-S anastomosis includes mesenteric sparing one other study suggests that 
more radical excision of the mesentery may also reduce recurrence.  On-going trials, of better 
quality, may confirm these data but further trials including the degree of mesenteric resection 
should be considered.
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Shimada (14) 215
37yrs (median)
117 98 39 34 (median) 84:33 74:24 - - 
Kono 2011(7) 142 69 73 31 (19-62) 28 (14–62) 57:12 58:15 25/69 (36%) 22/73 (30%)
Seyfried (15) 53 
37yrs (median) 
- - - - - - - -
Katsuno (19) 30 30 -
34 (23-48)
- 22:8 - 9/30 (38%)
Krane (31) 96 - - - - - - - -
Kono 2015 (16) 171 Japan 144
USA 45
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Table 4 Overview of judgement of risk of bias and methodological quality of included studies


































































Were there clear criteria for inclusion in the case 
series?
Yes Yes Unclear Yes Yes Were the two groups similar and recruited from the same 
population?
Yes Yes Yes
Was the condition measured in a standard, reliable 
way for all participants included in the case series?
Yes Yes Unclear Yes Yes Were the exposures measured similarly to assign people 
to both exposed and unexposed groups? Was the 
exposure measured in a valid and reliable way?
Yes Yes Yes
Were valid methods used for identification of the 
condition for all participants included in the case 
series?
Yes Yes Unclear Yes Yes Were confounding factors identified? Yes Unclear Unclear
Did the case series have consecutive inclusion of 
participants?
Yes No Yes Yes Unclear Were strategies to deal with confounding factors stated? Unclear No Yes
Did the case series have complete inclusion of 
participants?
Yes Yes Yes Yes Unclear Were the groups/participants free of the outcome at the 
start of the study (or at the moment of exposure)?
Yes Yes Yes
Was there clear reporting of the demographics of the 
participants in the study?
Yes Yes No Yes No Were the outcomes measured in a valid and reliable 
way?
Yes Yes Yes
Was there clear reporting of clinical information of 
the participants?
Yes Yes No Yes Yes Was the follow up time reported and sufficient to be 
long enough for outcomes to occur?
Yes Yes Yes
Were the outcomes or follow up results of cases 
clearly reported?
Yes No Unclear Yes No Was follow up complete, and if not, were the reasons to 
loss to follow up described   and explored?
No No Yes
Was there clear reporting of the presenting 
site(s)/clinic(s) demographic information?
Yes Yes No Yes No Were strategies to address incomplete follow up 
utilized?
No No Yes
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Table 5 Study results for surgical and endoscopic recurrence 
Study ID Surgical Recurrence Endoscopic recurrence (Mean Rutgeerts score)










4/117 (3.4%) 47.3 (mean) 24/98 (24.4%) 99 - - - -
Kono 2011 (7)
vs. end-to-end or 
side-to-side
0/69 60 11/73 (15%) 60 2.6i 60 3.4i 60
Luglio (29)
vs. side-to-side
0/36 24 2/43 24 1.05i 18 2.3i 18
Seyfried (15) 0/53 12 - - - - -
Katsuno (19) 0/30 35 - - - - - -
Krane (31) 0/96 36 - 0.7i 36 - -









Fichera (20) 0/46 (0%) 14 - - 0.7i  14 - -
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implications of key findings; systematic review registration number. 
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INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known. 3
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
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Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale. 
4-5
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additional studies) in the search and date last searched. 
5-6
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated. 
5-6
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis). 
5-6
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators. 
5-6
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
5-6
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis. 
6
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 6
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis. 
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Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified. 
7
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram. 
8 fig 1
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
8 table 1,2
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). 9 table 3
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
9-11 table 
4,5
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. 9-11 table 
4-5
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). Table 3
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). n/a
DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers). 
13-15
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias). 
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Study ID Total population  
Age  









1st comparison  
(Kono S) 
 Kono-S  
 
Comparator Kono-S  
 
Comparator - Comparator Kono-S  Comparator 
Shimada (14)  215 
37yrs (median) 
117 98 39  34 (median) 84:33 74:24 - -  
Kono 2011(7) 142  69 73 31 (19-62) 28 (14–62)  57:12 58:15  25/69 (36%) 22/73 (30%) 
Seyfried (15) 53  
37yrs (median)  
- - - - - - - - 
Katsuno (19) 30 30 - 
34 (23-48) 
- 22:8 - 9/30 (38%)  
Krane (31) 96 - - - - - - - - 
Kono 2015 (16) 171 Japan 144 
USA 45 
- Japan 31   
USA 32  
- Japan 110:34 
USA21:22 
-  Japan 35/135  
(26 %) 
USA 12/36 (33 %) 
- 
Fichera (20) 46  
33.5yrs (mean) 
- - - - - - - - 




43 (mean) 18:18 22:21 11 (38%) 10 (27%) 
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35.9 (mean) 
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Table 4 Overview of judgement of risk of bias and methodological quality of included studies 






















































Were there clear criteria for inclusion in the case 
series? 
Yes Yes Unclear Yes Yes Were the two groups similar and recruited from the same 
population? 
Yes Yes Yes 
Was the condition measured in a standard, reliable 
way for all participants included in the case series? 
Yes Yes Unclear Yes Yes Were the exposures measured similarly to assign people 
to both exposed and unexposed groups? Was the 
exposure measured in a valid and reliable way? 
Yes Yes Yes 
Were valid methods used for identification of the 
condition for all participants included in the case 
series? 
Yes Yes Unclear Yes Yes Were confounding factors identified? Yes Unclear Unclear 
Did the case series have consecutive inclusion of 
participants? 
Yes No Yes Yes Unclear Were strategies to deal with confounding factors stated? Unclear No Yes 
Did the case series have complete inclusion of 
participants? 
Yes Yes Yes Yes Unclear Were the groups/participants free of the outcome at the 
start of the study (or at the moment of exposure)? 
Yes Yes Yes 
Was there clear reporting of the demographics of the 
participants in the study? 
Yes Yes No Yes No Were the outcomes measured in a valid and reliable 
way? 
Yes Yes Yes 
Was there clear reporting of clinical information of 
the participants? 
Yes Yes No Yes Yes Was the follow up time reported and sufficient to be 
long enough for outcomes to occur? 
Yes Yes Yes 
Were the outcomes or follow up results of cases 
clearly reported? 
Yes No Unclear Yes No Was follow up complete, and if not, were the reasons to 
loss to follow up described   and explored? 
No No Yes 
Was there clear reporting of the presenting 
site(s)/clinic(s) demographic information? 
Yes Yes No Yes No Were strategies to address incomplete follow up 
utilized? 
No No Yes 
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Table 5 Study results for surgical and endoscopic recurrence  
Study ID Surgical Recurrence Endoscopic recurrence (Mean Rutgeerts score) 
 Kono S  Follow up 
Months (median) 
Comparator Follow up 
Months (median) 
Kono S  Follow up 
Months (median) 




4/117 (3.4%)  47.3 (mean) 24/98 (24.4%)  99  - - - - 
Kono 2011 (7) 
vs. end-to-end or 
side-to-side 
0/69 60 11/73 (15%) 60 2.6i  60 3.4i  60 
Luglio (29) 
vs. side-to-side 
0/36 24 2/43 24 1.05i  18 2.3i 18 
Seyfried (15) 0/53 12 - - -  - - 
Katsuno (19) 0/30 35 - - - - - - 
Krane (31) 0/96 36 -  0.7i  36 - - 
Kono 2015(16) Japan 2/144 (1.8 %)  
USA 0/29 (0%) 
Japan 120 
USA 32 





Fichera (20) 0/46 (0%) 14 - - 0.7i   14 - - 
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Seyfried (15) 53  
37yrs (median)  
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Katsuno (19) 30 30 - 
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- 22:8 - 9/30 (38%)  
Krane (31) 96 - - - - - - - - 
Kono 2015 (16) 171 Japan 144 
USA 45 
- Japan 31   
USA 32  
- Japan 110:34 
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-  Japan 35/135  
(26 %) 
USA 12/36 (33 %) 
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33.5yrs (mean) 
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population? 
Yes Yes Yes 
Was the condition measured in a standard, reliable 
way for all participants included in the case series? 
Yes Yes Unclear Yes Yes Were the exposures measured similarly to assign people 
to both exposed and unexposed groups? Was the 
exposure measured in a valid and reliable way? 
Yes Yes Yes 
Were valid methods used for identification of the 
condition for all participants included in the case 
series? 
Yes Yes Unclear Yes Yes Were confounding factors identified? Yes Unclear Unclear 
Did the case series have consecutive inclusion of 
participants? 
Yes No Yes Yes Unclear Were strategies to deal with confounding factors stated? Unclear No Yes 
Did the case series have complete inclusion of 
participants? 
Yes Yes Yes Yes Unclear Were the groups/participants free of the outcome at the 
start of the study (or at the moment of exposure)? 
Yes Yes Yes 
Was there clear reporting of the demographics of the 
participants in the study? 
Yes Yes No Yes No Were the outcomes measured in a valid and reliable 
way? 
Yes Yes Yes 
Was there clear reporting of clinical information of 
the participants? 
Yes Yes No Yes Yes Was the follow up time reported and sufficient to be 
long enough for outcomes to occur? 
Yes Yes Yes 
Were the outcomes or follow up results of cases 
clearly reported? 
Yes No Unclear Yes No Was follow up complete, and if not, were the reasons to 
loss to follow up described   and explored? 
No No Yes 
Was there clear reporting of the presenting 
site(s)/clinic(s) demographic information? 
Yes Yes No Yes No Were strategies to address incomplete follow up 
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